Dr. Sharon Wilczynski, MD
- Medicare services, 2023
- 727
- Publications
- 5
- MIPS score, 2024
- 93
- Industry payments
- $26
- Affiliated sites
- 1
- Practice address
- 1500 E Duarte Road, Duarte, CA
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
City of Hope Helford Clinical Research Hospital
Duarte, California
Find Dr. Wilczynski's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Sharon Wilczynski is a cytopathology physician in Duarte, California
Dr. Wilczynski practices at City of Hope Helford Clinical Research Hospital in Duarte, California.
Dr. Wilczynski's NPI, 1679539407, was assigned on April 21, 2006. Dr. Wilczynski graduated from MCP-Hahnemann College of Medicine in 1981. Dr. Wilczynski holds California license G52867.
- NPI
- 1679539407NPI Registry (opens in a new tab)
- NPI enumeration date
- April 21, 2006
- NPI status
- Active
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Medical school graduation
- 1981
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Sharon Wilczynski practices at City of Hope Helford Clinical Research Hospital in Duarte, California
Dr. Wilczynski's primary practice is City of Hope Helford Clinical Research Hospital, at 1500 E Duarte Road, Duarte, CA.
- City of Hope Helford Clinical Research Hospital1500 E Duarte Road, Duarte, CA
Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Sharon Wilczynski is affiliated with 1 site of care and 1 medical group
Dr. Wilczynski's primary practice is City of Hope Helford Clinical Research Hospital in Duarte, California. The medical group on file is City of Hope.
Sources: Dmand AI Affiliation Data; Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Sharon Wilczynski's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wilczynski practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| City of Hope Helford Clinical Research Hospital | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Sharon Wilczynski is one of 47 cytopathology physicians in California
Cytopathology is Dr. Wilczynski's primary specialty in the NPI Registry, under taxonomy code 207ZC0500X. Dr. Wilczynski is board certified in anatomic pathology & clinical pathology by the American Board of Pathology. Dmand AI has Dr. Wilczynski's licenses on file in 2 states: California and Pennsylvania.
Specialties and state licenses
- Cytopathology, CaliforniaPrimary
- Pennsylvania license
Cytopathology physicians near Dr. Wilczynski
Counts of cytopathology physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Sharon Wilczynski billed Medicare for 727 services in 2023
CMS data shows 727 Medicare services from Dr. Wilczynski across 10 procedure codes in 2023. Medicare paid $25,982 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Wilczynski's Medicare services by type, 2022 to 2023
- 2022
- 2023
- Lab and pathology
- 2022: 1,4562023: 72750%
Dr. Wilczynski compared with the California median for cytopathology physicians, 2023
- Dr. Wilczynski
- California median
- Medicare services
- 727vs 97626% below
Medians across 40 cytopathology physicians in California with Dmand AI profiles that report each measure.
Dr. Wilczynski's most billed Medicare procedure codes, 2023
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Wilczynski?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Wilczynski and other cytopathology physicians in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Sharon Wilczynski scored 93 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Wilczynski for performance year 2024, reported as part of a group.
Dr. Wilczynski's MIPS scores, performance year 2024
- 93of 100Final score
- 78.5of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 70of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Sharon Wilczynski has 5 publications on record
Dmand AI links 5 papers to Dr. Wilczynski, published from 2009 to 2024. 2009 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Cisplatin and Ovarian Neoplasms. Dr. Wilczynski has published most often in Gynecol Oncol. Dr. Wilczynski's most frequent co-authors are Bradley J. Monk, MD, Robert A. Burger, MD and John P P. Fruehauf, MD.
Dr. Wilczynski's papers by year, 2009 to 2024
Topics Dr. Wilczynski writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Cisplatin
- Ovarian Neoplasms
- Carboplatin
- Doxorubicin
- Paclitaxel
- Polyethylene Glycols
Dr. Wilczynski's most frequent co-authors
- Bradley J. Monk, MD2 shared papers
- Robert A. Burger, MD1 shared paper
- John P P. Fruehauf, MD1 shared paper
Recent publications by Dr. Wilczynski
See who Dr. Wilczynski researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Wilczynski works with, so you can find a warm path to the right cytopathology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Sharon Wilczynski received $26 in industry payments in 2023
CMS Open Payments shows 1 general payment to Dr. Wilczynski from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $26.
Companies that paid Dr. Wilczynski the most, 2023 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Sharon Wilczynski graduated from MCP-Hahnemann College of Medicine
Dr. Wilczynski graduated from MCP-Hahnemann College of Medicine in 1981.
- Medical school
- Board certified in anatomic pathology & clinical pathology
- Board certified in cytopathology
Source: Dmand AI Professional Profile Data
Dr. Sharon Wilczynski accepts plans from 1 insurance carrier
Dr. Wilczynski is in network with 1 carrier, including Aetna. HMO plans come from the most carriers, 1. Check the plan with the practice before a visit.
- Aetna
Source: Dmand AI Insurance Network Data
Sources for Dr. Sharon Wilczynski's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Sharon Wilczynski
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Sharon Wilczynski's NPI number?
Dr. Sharon Wilczynski's NPI number is 1679539407. It was assigned on April 21, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Sharon Wilczynski?
Dr. Sharon Wilczynski is a cytopathology physician in Duarte, California. The primary specialty in the NPI Registry is Cytopathology Physician (taxonomy code 207ZC0500X).
Where does Dr. Sharon Wilczynski practice?
Dr. Wilczynski practices at 1500 E Duarte Road, Duarte, CA. Dr. Wilczynski's primary practice is City of Hope Helford Clinical Research Hospital in Duarte, California.
What is Dr. Sharon Wilczynski's medical license number?
Dr. Wilczynski holds California license G52867, one of the licenses on file in 2 states.
Which states has Dr. Sharon Wilczynski been licensed in?
Dmand AI has state licenses on file for Dr. Wilczynski in California (1984 to 2026) and Pennsylvania (1983 to 2004).
What medical group is Dr. Sharon Wilczynski part of?
Dr. Wilczynski is linked to City of Hope.
Does Dr. Sharon Wilczynski accept Medicare?
Yes. CMS data shows Dr. Wilczynski billed Medicare for 727 services in 2023.
What is Dr. Sharon Wilczynski's MIPS score?
Dr. Wilczynski's MIPS final score for performance year 2024 is 93 out of 100, reported as part of a group.
Is Dr. Sharon Wilczynski board certified?
Yes. Dr. Wilczynski is board certified in anatomic pathology & clinical pathology by the American Board of Pathology.
What services does Dr. Sharon Wilczynski bill to Medicare?
In 2023, Dr. Wilczynski's most billed Medicare services were lab and pathology test (88305), lab and pathology test (88341) and lab and pathology test (88108).
Show 6 more questionsShow fewer questions
Where did Dr. Sharon Wilczynski go to medical school?
Dr. Wilczynski graduated from MCP-Hahnemann College of Medicine in 1981.
Has Dr. Sharon Wilczynski received payments from drug or device companies?
CMS Open Payments shows $26 in general payments to Dr. Wilczynski from 1 company from 2023 to 2023. The largest total came from Regeneron Pharmaceuticals, Inc.
How long has Dr. Sharon Wilczynski been practicing?
Dr. Wilczynski graduated from medical school in 1981, 45 years ago.
Does Dr. Sharon Wilczynski do research?
Dmand AI links 5 publications to Dr. Wilczynski, published from 2009 to 2024.
Who does Dr. Sharon Wilczynski publish with?
Dr. Wilczynski's most frequent co-authors are Bradley J. Monk, MD (2 shared papers), Robert A. Burger, MD (1 shared paper) and John P P. Fruehauf, MD (1 shared paper).
What insurance does Dr. Sharon Wilczynski accept?
Dr. Wilczynski is in network with 1 carrier, including Aetna. HMO plans come from the most carriers, 1. Check the plan with the practice before a visit.
Selling to cytopathology practices?
See cytopathology physicians in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card